These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22974254)

  • 21. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy.
    Ko SH; Kwon HS; Yu JM; Baik SH; Park IB; Lee JH; Ko KS; Noh JH; Kim DS; Kim CH; Mok JO; Park TS; Son HS; Cha BY
    Diabet Med; 2010 Sep; 27(9):1033-40. PubMed ID: 20722677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND).
    Rosales RL; Santos MM; Mercado-Asis LB
    Angiology; 2011 Nov; 62(8):625-35. PubMed ID: 21733952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy.
    Freeman R; Raskin P; Hewitt DJ; Vorsanger GJ; Jordan DM; Xiang J; Rosenthal NR;
    Curr Med Res Opin; 2007 Jan; 23(1):147-61. PubMed ID: 17257476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.
    Valensi P; Le Devehat C; Richard JL; Farez C; Khodabandehlou T; Rosenbloom RA; LeFante C
    J Diabetes Complications; 2005; 19(5):247-53. PubMed ID: 16112498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of cilostazol on peripheral neuropathy in diabetic patients with peripheral arterial disease.
    O'Donnell ME; Badger SA; Sharif MA; Makar RR; Young IS; Lee B; Soong CV
    Angiology; 2008 Dec-2009 Jan; 59(6):695-704. PubMed ID: 18796444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria.
    Choi YM; Kwon HS; Choi KM; Lee WY; Hong EG
    Endocrinol Metab (Seoul); 2019 Dec; 34(4):398-405. PubMed ID: 31884740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus.
    Shehab D; Al-Jarallah K; Abdella N; Mojiminiyi OA; Al Mohamedy H
    Med Princ Pract; 2015; 24(3):250-6. PubMed ID: 25720672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multicenter, randomized, positive-controlled clinical study for the effects of nerotropin on diabetic neuropathy].
    Ning G; Zou DJ; Liu W; Xing HL; Zhang W; Zhao YJ; Lu J; Xu H; Jin J
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1785-7. PubMed ID: 15631774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
    Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
    Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventive effect of an oral prostacyclin analog, beraprost sodium, on digital necrosis in systemic sclerosis. French Microcirculation Society Multicenter Group for the Study of Vascular Acrosyndromes.
    Vayssairat M
    J Rheumatol; 1999 Oct; 26(10):2173-8. PubMed ID: 10529135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
    Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
    J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial.
    Won JC; Kwon HS; Moon SS; Chun SW; Kim CH; Park IB; Kim IJ; Lee J; Cha BY; Park TS
    Diabetes Metab J; 2020 Aug; 44(4):542-554. PubMed ID: 31701699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Clinical Trial of Nitrosense patch for the treatment of patients with painful diabetic neuropathy.
    Agrawal RP; Jain S; Goyal S; Singhal S; Lindgren L; Sthengel E
    J Assoc Physicians India; 2014 May; 62(5):385-90. PubMed ID: 25438482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A Randomized Clinical Trial.
    ; Hor CP; Fung WY; Ang HA; Lim SC; Kam LY; Sim SW; Lim LH; Choon WY; Wong JW; Ch'ng ASH; Beh KKM; Wee HC; Ong LM; Khan NAK; Sulaiman SAS; Shuaib IL; Bakar A; Yusof Y; Yusof YM; Abu Bakar F; Tang WS; Teh HL; Wahid NA; Saaidin S; Idris N; Yoon CK; Ong HN; Ganapathy JT; Loo CE; Samy MM; Zainal H; Dharan SCS; Ooi BY; Teoh PY; Tye YL; Yeoh CA; Low DW; Looi I; Yuen KH
    JAMA Neurol; 2018 Apr; 75(4):444-452. PubMed ID: 29379943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy.
    Na KY; Kim DK; Kim SG; Lee YK; Lim CS
    Trials; 2013 Sep; 14():275. PubMed ID: 24066672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER).
    Kharitonova T; Shvarts YG; Verbovoy AF; Orlova NS; Puzyreva VP; Strokov IA
    BMJ Open Diabetes Res Care; 2022 Jun; 10(3):. PubMed ID: 35680173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effect of beraprost sodium on lower limb circulation in patients with non-insulin-dependent diabetes mellitus-evaluation by color Doppler ultrasonography and laser cutaneous blood flowmetry.
    Okuda Y; Sone H; Mizutani S; Asano M; Tsurushima Y; Ogawa M; Tada K; Asakura Y; Kawakami Y; Suzuki S; Yamashita K
    Prostaglandins; 1996 Nov; 52(5):375-84. PubMed ID: 8948505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.